Toggle Main Menu Toggle Search

Open Access padlockePrints

Potent and Selective KDM5 Inhibitor Stops Cellular Demethylation of H3K4me3 at Transcription Start Sites and Proliferation of MM1S Myeloma Cells

Lookup NU author(s): Professor Akane Kawamura

Downloads


Licence

This work is licensed under a Creative Commons Attribution 4.0 International License (CC BY 4.0).


Abstract

© 2017 The Authors Methylation of lysine residues on histone tail is a dynamic epigenetic modification that plays a key role in chromatin structure and gene regulation. Members of the KDM5 (also known as JARID1) sub-family are 2-oxoglutarate (2-OG) and Fe2+-dependent oxygenases acting as histone 3 lysine 4 trimethyl (H3K4me3) demethylases, regulating proliferation, stem cell self-renewal, and differentiation. Here we present the characterization of KDOAM-25, an inhibitor of KDM5 enzymes. KDOAM-25 shows biochemical half maximal inhibitory concentration values of <100 nM for KDM5A-D in vitro, high selectivity toward other 2-OG oxygenases sub-families, and no off-target activity on a panel of 55 receptors and enzymes. In human cell assay systems, KDOAM-25 has a half maximal effective concentration of ∼50 μM and good selectivity toward other demethylases. KDM5B is overexpressed in multiple myeloma and negatively correlated with the overall survival. Multiple myeloma MM1S cells treated with KDOAM-25 show increased global H3K4 methylation at transcriptional start sites and impaired proliferation.


Publication metadata

Author(s): Tumber A, Nuzzi A, Hookway ES, Hatch SB, Velupillai S, Johansson C, Kawamura A, Savitsky P, Yapp C, Szykowska A, Wu N, Bountra C, Strain-Damerell C, Burgess-Brown NA, Ruda GF, Fedorov O, Munro S, England KS, Nowak RP, Schofield CJ, La Thangue NB, Pawlyn C, Davies F, Morgan G, Athanasou N, Muller S, Oppermann U, Brennan PE

Publication type: Article

Publication status: Published

Journal: Cell Chemical Biology

Year: 2017

Volume: 24

Issue: 3

Pages: 371-380

Print publication date: 16/03/2017

Online publication date: 02/03/2017

Acceptance date: 01/02/2017

Date deposited: 11/10/2019

ISSN (print): 2451-9456

ISSN (electronic): 2451-9448

Publisher: Elsevier Ltd

URL: https://doi.org/10.1016/j.chembiol.2017.02.006

DOI: 10.1016/j.chembiol.2017.02.006

PubMed id: 28262558


Altmetrics

Altmetrics provided by Altmetric


Funding

Funder referenceFunder name
A.K. is a Royal Society Dorothy Hodgkin Research Fellow

Share